This compound is a pharmaceutical intermediate used as a reference standard for identifying and quantifying impurities in Acalabrutinib. It features a complex polycyclic structure with multiple aromatic rings and amide functional groups, making it suitable for analytical quality control in pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Acalabrutinib Impurity 21
research compound
(2R)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-Pyrrolidinecarboxylic acid phenylmethyl ester
pharmaceutical intermediate
Acalabrutinib Impurity 10
pharmaceutical intermediate
L-Alanine methyl ester hydrochloride
pharmaceutical intermediate
Ethyl (R)-3-hydroxybutanoate
pharmaceutical intermediate
Dexamethasone 9,11-epoxide
pharmaceutical intermediate
2-Chloro-1,3-bis(dimentylamino)trimethinium hexafluorophosphate
pharmaceutical intermediate
4-[5-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]-10-methyl-12-oxo-4,6,9,13-tetrazatricyclo[7.4.0.02,6]trideca-1(13),2,4,7,10-pentaen-3-yl]-N-pyridin-2-ylbenzamide
DBIHVGGBNOQUGX-QFIPXVFZSA-N
CC#CC(=O)N1CCC[C@H]1C2=NC(=C3N2C=CN4C3=NC(=O)C=C4C)C5=CC=C(C=C5)C(=O)NC6=CC=CC=N6
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.